1. OnabotulinumtoxinA, Nerve Stimulation Devices, Mirabegron, and Anticholinergics Versus Best Supportive Care for Overactive Bladder: An Updated US Cost-Effectiveness Analysis. (July 2022) Authors: Murray, Brian; Miles-Thomas, Jennifer; Sussman, David; Park, Amy J.; Chermansky, Christopher; Nguyen, Victor; Tung, Amy; Gillard, Patrick; Lalla, Anjana; Nitti, Victor Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗